Affiliation:
1. Department of Medicine, Louisiana State University Medical Center, New Orleans 70112, USA.
Abstract
A total of 590 strains of clinically important anaerobes were tested to determine their susceptibility to trovafloxacin. Overall, trovafloxacin had a mode MIC of 0.25 micrograms/ml and a MIC at which 90% of the isolates were inhibited of 1 micrograms/ml and had activity comparable to that of metronidazole. Trovafloxacin was 8-, 8-, 16-, 32-, and 64-fold more active than ampicillin-sulbactam, clindamycin, ciprofloxacin, cefoxitin, and cefotetan, respectively. Of the Bacteroides fragilis group, 97% of the isolates were inhibited by trovafloxacin at 21 micrograms/ml, and trovafloxacin was more active than ciprofloxacin, cefoxitin, cefotetan, ampicillin-sulbactam, and clindamycin against Clostridium, Fusobacterium, Porphyromonas, and Prevotella strains.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. Increased activity of a new chlorofluoroquinolone, BAY y3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria;Aldridge K. E.;Antimicrob. Agents Chemother.,1994
2. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria;Borobio M. V.;Antimicrob. Agents Chemother.,1984
3. The in vitro activity of trovafloxacin, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents;Child J.;J. Antimicrob. Chemother.,1995
4. In vitro activity of trovafloxacin, a new fluoroquinolone, against clinical isolates of gram-positive bacteria;Eliopoulos G. M.;Antimicrob. Agents Chemother.,1993
5. In vivo efficacy of trovafloxacin (CP 99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae and Bacteroides fragilis;Girard A. E.;Antimicrob. Agents Chemother.,1995
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献